JILLIAN EASTMAN: Open Payments
NPI 1336253285 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 26 payments from 9 companies in 2025. Trend: 2023 $854 · 2024 $1,123 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $253 |
| Verona Pharma, Inc. | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| GlaxoSmithKline, LLC. | 2 | $56 |
| PFIZER INC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $14 |
Products named: TEZSPIRE, BREZTRI, Ohtuvayre, ACTHAR, NUCALA, GLASSIA, PANZYGA, FASENRA.
Industry payments across NY — which companies pay providers there.
